Digital health company Luminopia Inc. announced real-world data from the Patients Using Prescription Luminopia Registry, which demonstrated the efficacy of its binocular, virtual reality-based medical device for children with amblyopia.
“The analysis of real-world data from the PUPiL registry demonstrates the benefit of digital therapy in improving outcomes for amblyopia,” Derek Sprunger, MD, FAAO, professor at Indiana University School of Medicine, said in a company press release. “Luminopia’s unique mechanism of action, which doesn’t just penalize the strong eye